The Selective Inhibitor of the CXCR4 Chemokine Receptor Market has become one of the more dynamic areas in oncology and immunology. Growing knowledge of the CXCR4 receptor has shown its central role in cancer biology, from tumor progression and metastasis to immune regulation and resistance to therapy. Once regarded as a niche target, CXCR4 has moved into mainstream focus because of its...